BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34539820)

  • 1. COL4A1 as a novel oncogene associated with the clinical characteristics of malignancy predicts poor prognosis in glioma.
    Wang H; Liu Z; Li A; Wang J; Liu J; Liu B; Lian X; Zhang B; Pang B; Liu L; Gao Y
    Exp Ther Med; 2021 Nov; 22(5):1224. PubMed ID: 34539820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormally high expression of HOXA2 as an independent factor for poor prognosis in glioma patients.
    Liu Z; Shen F; Wang H; Li A; Wang J; Du L; Liu B; Zhang B; Lian X; Pang B; Liu L; Gao Y
    Cell Cycle; 2020 Jul; 19(13):1632-1640. PubMed ID: 32436804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic role of mitochondrial pyruvate carrier in isocitrate dehydrogenase-mutant glioma.
    Karsy M; Guan J; Huang LE
    J Neurosurg; 2018 Mar; 130(1):56-66. PubMed ID: 29547090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trophinin-associated protein expression correlates with shorter survival of patients with glioma: a study based on multiple data fusion analysis.
    Sun Y; Liu ZD; Liu RZ; Lian XY; Cheng XB; Jia YL; Liu BF; Gao YZ; Wang X
    Mol Biol Rep; 2022 Aug; 49(8):7899-7909. PubMed ID: 35708862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calponin 3 Acts as a Potential Diagnostic and Prognostic Marker and Promotes Glioma Cell Proliferation, Migration, and Invasion.
    Xie Y; Ding W; Xiang Y; Wang X; Yang J
    World Neurosurg; 2022 Sep; 165():e721-e731. PubMed ID: 35792226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CENPA acts as a prognostic factor that relates to immune infiltrates in gliomas.
    Wang B; Wei W; Long S; Wang L; Yang B; Wu D; Li Z; Li Z; Arshad M; Li X; Chen J
    Front Neurol; 2022; 13():1015221. PubMed ID: 36341103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High TRAF3IP3 Level Predicts Poor Prognosis of Patients with Gliomas.
    Yang G; Tang S; Zhang J; Qin L
    World Neurosurg; 2021 Apr; 148():e436-e449. PubMed ID: 33444836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic and prognostic utility of eIF6 in glioblastoma: a study based on TCGA and CGGA databases.
    Liang J; Liu F; Yang Y; Li X; Cai G; Cao J; Zhang B
    Am J Transl Res; 2022; 14(7):5040-5049. PubMed ID: 35958479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal expression of
    Wang J; Liu Z; Zhang C; Wang H; Li A; Liu B; Lian X; Ren Z; Zhang W; Wang Y; Zhang B; Pang B; Gao Y
    PeerJ; 2021; 9():e10820. PubMed ID: 33614284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between PLOD1 expression level and glioma prognosis investigated using public databases.
    Tian L; Zhou H; Wang G; Wang WY; Li Y; Xue X
    PeerJ; 2021; 9():e11422. PubMed ID: 34040895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of
    Yu Z; Liu Z; Lian X; Cheng X; Liu B; Zhang B; Wang H; Wang J; Li A; Ren Z; Pang B; Qian R; Gao Y
    Cell Cycle; 2022 Nov; 21(22):2387-2402. PubMed ID: 35852388
    [No Abstract]   [Full Text] [Related]  

  • 12. EDEM2 is a diagnostic and prognostic biomarker and associated with immune infiltration in glioma: A comprehensive analysis.
    Wu Y; Wang H; Xiang W; Yi D
    Front Oncol; 2022; 12():1054012. PubMed ID: 36727065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of CYP2E1 is associated with poor prognosis and tumor progression of gliomas.
    Ye L; Xu Y; Wang L; Zhang C; Hu P; Tong S; Liu Z; Tian D
    Cancer Med; 2021 Nov; 10(22):8100-8113. PubMed ID: 34612013
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Liu Z; Ren Z; Zhang C; Qian R; Wang H; Wang J; Zhang W; Liu B; Lian X; Wang Y; Guo Y; Gao Y
    Front Oncol; 2021; 11():608748. PubMed ID: 34976781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between small heat shock protein B11 and the prognostic value of MGMT promoter methylation in patients with high-grade glioma.
    Cheng W; Li M; Jiang Y; Zhang C; Cai J; Wang K; Wu A
    J Neurosurg; 2016 Jul; 125(1):7-16. PubMed ID: 26544773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Elevated Expression Levels of
    Shin HJ; Gil M; Lee IS
    J Pers Med; 2022 Mar; 12(4):. PubMed ID: 35455650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and clinical significance of
    Ren Z; Ma S; Cheng X; Guo Y; Liu Z
    Int J Clin Exp Pathol; 2021; 14(9):938-955. PubMed ID: 34646412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD74 Correlated With Malignancies and Immune Microenvironment in Gliomas.
    Xu S; Li X; Tang L; Liu Z; Yang K; Cheng Q
    Front Mol Biosci; 2021; 8():706949. PubMed ID: 34540893
    [No Abstract]   [Full Text] [Related]  

  • 19. Up-regulation of MARVEL domain-containing protein 1 (MARVELD1) accelerated the malignant phenotype of glioma cancer cells via mediating JAK/STAT signaling pathway.
    Xia L; Jin P; Tian W; Liang S; Tan L; Li B
    Braz J Med Biol Res; 2021; 54(7):e10236. PubMed ID: 34008750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic biomarker HIF1α and its correlation with immune infiltration in gliomas.
    Ding Z; Zhang J; Li L; Wang C; Mei J
    Oncol Lett; 2024 May; 27(5):193. PubMed ID: 38495835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.